Proteins and Peptides
14 August 2013
MannKind Reports Positive Data from a Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes14 August 2013
MannKind Reports Positive Data from a Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes13 August 2013
Dance Biopharm Announces Encouraging Clinical Data for Adagio™– Inhalable Insulin Product Candidate for Diabetes6 August 2013
The Medicines Company Announces Positive Phase III Trial Results for Fibrocaps; Completes ProFibrix Acquisition5 August 2013
BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia1 August 2013
Cerevast Therapeutics Initiates Phase 3 Clotbust ER™ Clinical Study for the Treatment of Acute Ischemic Stroke19 July 2013
US and EU Regulatory Authorities Accept PLEGRIDY™ (peginterferon beta-1a) Marketing Applications for Review17 July 2013
Synergy Pharmaceuticals’ Plecanatide Phase 2b Trial in IBS-C Reaches Enrollment Halfway Mark11 July 2013
Biodel Announces Completion of Dosing in Phase 2 Clinical Trial of BIOD-123 in Patients With Type 1 DiabetesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports